Martina M Porath Selected Research

Tocolysis

5/2016	Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
1/2016	Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
4/2015	Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).
3/2015	Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.
1/2015	Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
1/2013	Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
9/2009	Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martina M Porath Research Topics

Disease

13	Premature Obstetric Labor (Premature Labor) 03/2020 - 09/2009
6	Premature Birth (Birth, Premature) 12/2016 - 09/2009
3	Asphyxia (Suffocation) 12/2022 - 02/2010
3	Uterine Hemorrhage (Uterine Bleeding) 02/2017 - 09/2015
2	Preterm Premature Rupture of the Membranes 01/2019 - 10/2015
1	Oligohydramnios 01/2019
1	Rupture 01/2019
1	Gestational Weight Gain 01/2016
1	Malnutrition (Nutritional Deficiencies) 01/2016
1	Nausea 01/2016
1	Hyperemesis Gravidarum 01/2016
1	Vomiting 01/2016
1	Dehydration (Water Stress) 01/2016
1	Fetal Hypoxia 05/2015
1	Body Weight (Weight, Body) 01/2015
1	Periventricular Leukomalacia (Neonatal Cerebral Leukomalacia) 04/2014
1	Lung Diseases (Lung Disease) 04/2014
1	Chorioamnionitis 04/2014
1	Prolapse 04/2014
1	Wounds and Injuries (Trauma) 04/2014
1	Abruptio Placentae (Placental Abruption) 04/2014
1	Necrotizing Enterocolitis 04/2014
1	Neonatal Sepsis 04/2014
1	Hemorrhage 04/2014
1	Meningitis 03/2014
1	Pneumothorax 03/2014
1	Pain (Aches) 07/2012
1	Reperfusion Injury 02/2010
1	Hypoxia (Hypoxemia) 02/2010
1	Brain Diseases (Brain Disorder) 02/2010

Drug/Important Bio-Agent (IBA)

13	Fibronectins (Fibronectin)IBA 03/2020 - 09/2009
5	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2016 - 09/2009
5	Nifedipine (Adalat)FDA LinkGeneric 05/2016 - 01/2013
2	Allopurinol (Remid)FDA LinkGeneric 05/2015 - 02/2010
1	Soaps (Soap)IBA 02/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 05/2016
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2016
1	atosibanIBA 05/2016
1	C-Reactive ProteinIBA 09/2015
1	Biomarkers (Surrogate Marker)IBA 05/2015
1	TabletsIBA 01/2015
1	Remifentanil (Ultiva)FDA Link 07/2012
1	hexanoic acid (hexanoate)IBA 09/2011
1	Xanthine OxidaseIBA 02/2010
1	Free RadicalsIBA 02/2010
1	Tocolytic Agents (Tocolytics)IBA 09/2009

Therapy/Procedure

7	Tocolysis 05/2016 - 09/2009
1	Cesarean Section (Caesarean Section) 12/2022
1	Induced Labor 01/2019
1	Length of Stay 01/2016
1	Aftercare (After-Treatment) 01/2016
1	Enteral Nutrition (Feeding, Tube) 01/2016
1	Punctures 04/2014
1	Neonatal Intensive Care 03/2014
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 07/2012
1	Contraindications 07/2012
1	Epidural Analgesia 07/2012
1	Analgesia 07/2012